Defining future directions in spinal cord tumor research

Proceedings from the National Institutes of Health workshop

Restricted access

The relative rarity of spinal cord tumors has hampered the study of these uncommon nervous system malignancies. Consequently, the understanding of the fundamental biology and optimal treatment of spinal cord tumors is limited, and these cancers continue to inflict considerable morbidity and mortality in children and adults. As a first step to improving the outcome of patients affected with spinal cord tumors, the National Institutes of Health Office of Rare Diseases Research in cooperation with the National Cancer Institute and the National Institute of Neurological Disorders and Stroke convened a workshop to discuss the current status of research and clinical management of these tumors. The overall goal of this meeting was to initiate a process that would eventually translate fundamental basic science research into improved clinical care for this group of patients. Investigational priorities for each of these areas were established, and the opportunities for future multidisciplinary research collaborations were identified.

Abbreviations used in this paper:CBTRUS = Central Brain Tumor Registry of the United States; NIH = National Institutes of Health.

Article Information

Address correspondence to: Elizabeth B. Claus, M.D., Ph.D., Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College Street, P.O. Box 208034, New Haven, CT 06520-8034. email: or Richard J. Gilbertson, M.D., Ph.D., Department of Developmental Neurobiology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678. email:

© AANS, except where prohibited by US copyright law.



  • 1

    Abdel-Wahab MEtuk BPalermo JShirato HKresl JYapicier O: Spinal cord gliomas: a multi-institutional retrospective analysis. Int J Radiat Oncol Biol Phys 64:106010712006

    • Search Google Scholar
    • Export Citation
  • 2

    American College of Surgeons: National Cancer Data Base (NCDB): [Accessed October 14 2009]

  • 3

    Banerjee DHegedus BGutmann DHGarbow JR: Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo. Neuroimage 35:143414372007

    • Search Google Scholar
    • Export Citation
  • 4

    Central Brain Tumor Registry of the United States (CBTRUS): Primary (malignant and non-malignant) brain and central nervous system tumor incidence rates by site and gender age-adjusted to the 2000 US Standard Population Cbtrus 1998–2002 [Accessed October 14 2009]

    • Search Google Scholar
    • Export Citation
  • 5

    Department of Health and Human Services Centers for Disease Control and Prevention: National Program of Cancer Registries (NPCR) [Accessed October 14 2009]

    • Search Google Scholar
    • Export Citation
  • 6

    Fehlings MGRao SCSpinal cord and spinal column tumors. Bernstein MBerger MS: Neuro-Oncology: The Essentials New YorkThieme Publishers2000. 445464

    • Search Google Scholar
    • Export Citation
  • 7

    Malia's CORD Foundation: [Accessed October 14 2009]

  • 8

    National Cancer Institute: Surveillance Epidemiology and End Results Program (SEER) [Accessed October 14 2009]

  • 9

    Preston-Martin SMonroe KLee PJBernstein LKelsey JHenderson S: Spinal meningiomas in women in Los Angeles County: investigation of an etiological hypothesis. Cancer Epidemiol Biomarkers Prev 4:3333391995

    • Search Google Scholar
    • Export Citation
  • 10

    Public Law 107-260: the Benign Brain Tumor Cancer Registries Amendment Act. ( [Accessed October 14 2009]

    • Export Citation
  • 11

    Spinal Cord Tumor Association Inc: [Accessed October 14 2009]




All Time Past Year Past 30 Days
Abstract Views 265 265 23
Full Text Views 74 71 0
PDF Downloads 164 142 0
EPUB Downloads 0 0 0


Google Scholar